• Canada

Canadian Biotech Stocks Analysis

TSX:BLU
TSX:BLU
TSX:BLUBiotechs

Shareholders might want to keep a close eye on BELLUS Health Inc. (TSE:BLU) after insiders sold US$2.8m stock earlier this year

June 28, 2022
While BELLUS Health Inc. ( TSE:BLU ) shareholders have enjoyed a good week with stock up 7.7%, they need remain...
TSX:EDT
TSX:EDT
TSX:EDTBiotechs

When Will Spectral Medical Inc. (TSE:EDT) Turn A Profit?

June 28, 2022
With the business potentially at an important milestone, we thought we'd take a closer look at Spectral Medical Inc.'s...
TSX:PMN
TSX:PMN
TSX:PMNBiotechs

Despite Lacking Profits ProMIS Neurosciences (TSE:PMN) Seems To Be On Top Of Its Debt

June 23, 2022
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
TSX:MDNA
TSX:MDNA
TSX:MDNABiotechs

When Will Medicenna Therapeutics Corp. (TSE:MDNA) Breakeven?

June 15, 2022
We feel now is a pretty good time to analyse Medicenna Therapeutics Corp.'s ( TSE:MDNA ) business as it appears the...
TSXV:COV
TSXV:COV
TSXV:COVBiotechs

Covalon Technologies Ltd. (CVE:COV) insiders recover some losses but still CA$17k away from matching original investment

June 03, 2022
Some of the losses seen by insiders who purchased CA$184k worth of Covalon Technologies Ltd. ( CVE:COV ) shares over...
TSX:TH
TSX:TH
TSX:THBiotechs

Theratechnologies (TSE:TH) Is Making Moderate Use Of Debt

May 21, 2022
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
TSX:MBX
TSX:MBX
TSX:MBXBiotechs

Could The Market Be Wrong About Microbix Biosystems Inc. (TSE:MBX) Given Its Attractive Financial Prospects?

May 20, 2022
Microbix Biosystems (TSE:MBX) has had a rough three months with its share price down 15%. However, stock prices are...
TSX:MBX
TSX:MBX
TSX:MBXBiotechs

Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

May 20, 2022
Unsurprisingly, Microbix Biosystems Inc.'s ( TSE:MBX ) stock price was strong on the back of its healthy earnings...
TSX:HBP
TSX:HBP
TSX:HBPBiotechs

Insiders may be rethinking their CA$3.0m Helix BioPharma Corp. (TSE:HBP) investment now that the company has lost CA$5.0m in value

May 17, 2022
The recent 15% drop in Helix BioPharma Corp.'s ( TSE:HBP ) stock could come as a blow to insiders who purchased CA$3.0m...
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.